Shares of Moderna and Metagenomi, backed by Bayer, fell 32%
Shares of Metagenomi Technologies, a genetic drug company backed by Bayer Healthcare, opens a new tab and Moderna, opens a new tab, fell 32% during its debut on the Nasdaq. The stock opened for trading at $10.25, compared to its IPO price of $15 per share.
POPULAR POSTS
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM